- Home
- PRTA vs ETWO Comparison
PRTA vs ETWO Comparison
Compare PRTA & ETWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- ETWO
- Stock Information
- Founded
- PRTA 2012
- ETWO 2000
- Country
- PRTA Ireland
- ETWO United States
- Employees
- PRTA N/A
- ETWO N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- ETWO EDP Services
- Sector
- PRTA Health Care
- ETWO Technology
- Exchange
- PRTA Nasdaq
- ETWO Nasdaq
- Market Cap
- PRTA 802.8M
- ETWO 936.3M
- IPO Year
- PRTA N/A
- ETWO N/A
- Fundamental
- Price
- PRTA $13.41
- ETWO $2.97
- Analyst Decision
- PRTA Buy
- ETWO Sell
- Analyst Count
- PRTA 7
- ETWO 3
- Target Price
- PRTA $57.67
- ETWO $3.70
- AVG Volume (30 Days)
- PRTA 448.2K
- ETWO 983.3K
- Earning Date
- PRTA 11-12-2024
- ETWO 01-07-2025
- Dividend Yield
- PRTA N/A
- ETWO N/A
- EPS Growth
- PRTA N/A
- ETWO N/A
- EPS
- PRTA N/A
- ETWO N/A
- Revenue
- PRTA $133,350,000.00
- ETWO $619,301,000.00
- Revenue This Year
- PRTA $46.28
- ETWO N/A
- Revenue Next Year
- PRTA N/A
- ETWO $3.01
- P/E Ratio
- PRTA N/A
- ETWO N/A
- Revenue Growth
- PRTA N/A
- ETWO N/A
- 52 Week Low
- PRTA $12.31
- ETWO $2.80
- 52 Week High
- PRTA $41.55
- ETWO $5.08
- Technical
- Relative Strength Index (RSI)
- PRTA 43.50
- ETWO 39.84
- Support Level
- PRTA $12.31
- ETWO $2.89
- Resistance Level
- PRTA $14.28
- ETWO $3.12
- Average True Range (ATR)
- PRTA 0.98
- ETWO 0.12
- MACD
- PRTA 0.00
- ETWO 0.00
- Stochastic Oscillator
- PRTA 33.73
- ETWO 35.23
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About ETWO E2open Parent Holdings Inc.Class A
E2open Parent Holdings Inc is an end-to-end and cloud-based supply chain management SaaS platform. The company's software combines networks, data, and applications to provide a deeply embedded, mission-critical platform that allows customers to optimize the supply chain across channel shaping, business planning, logistics, trade, manufacturing, and supply management. The Group has one reportable segment consisting of cloud-based, end-to-end SCM software. Geographically, the company operates in the Americas, Europe, and Asia Pacific, out of which the majority is from the Americas.